CRP and Salla disease: Russo et al. described the UDIPROVE protocol in the management of SD and showed that the combined utilization of 18F-FDG PET/CT and C-reactive protein (CRP) exhibits heightened precision in tracking therapy response, thus facilitating the timely assessment of treatment efficacy [111].